Log In
BCIQ
Print this Print this
 

vonapanitase (formerly PRT-201)

  Manage Alerts
Collapse Summary General Information
Company Proteon Therapeutics Inc.
DescriptionRecombinant human elastase
Molecular Target Elastin (ELN)
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/09/2009

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today